Amring Pharms Company Profile

✉ Email this page to a colleague

AMRING PHARMS has fourteen approved drugs.

There are eight US patents protecting AMRING PHARMS drugs.

There are eight patent family members on AMRING PHARMS drugs in two countries and thirty-one supplementary protection certificates in ten countries.

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amring Pharms	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	INJECTABLE;INJECTION	210231-001	Jun 4, 2018	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Amring Pharms	BROMFENAC SODIUM	bromfenac sodium	SOLUTION/DROPS;OPHTHALMIC	202030-001	Jan 9, 2013		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Amring Pharms	LAMOTRIGINE	lamotrigine	TABLET, ORALLY DISINTEGRATING;ORAL	214124-004	Feb 3, 2022	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Amring Pharms	CIPROFLOXACIN HYDROCHLORIDE	ciprofloxacin hydrochloride	SOLUTION/DROPS;OPHTHALMIC	078598-001	Jan 16, 2008		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Amring Pharms	LYSTEDA	tranexamic acid	TABLET;ORAL	022430-001	Nov 13, 2009	AB	RX	Yes	Yes	8,022,106	⤷ Try a Trial				⤷ Try a Trial
Amring Pharms	ARSENIC TRIOXIDE	arsenic trioxide	INJECTABLE;INJECTION	210802-001	Nov 13, 2018	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Amring Pharms	NEOSTIGMINE METHYLSULFATE	neostigmine methylsulfate	SOLUTION;INTRAVENOUS	210989-002	Aug 22, 2018	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Tablets	650 mg	➤ Subscribe	2011-05-24

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
Japan	2011168596	⤷ Try a Trial
Japan	2014193878	⤷ Try a Trial
Japan	5000504	⤷ Try a Trial
Japan	2008508275	⤷ Try a Trial
Japan	5205053	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2006023000	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2006023001	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0364417	97C0128	France	⤷ Try a Trial	PRODUCT NAME: LATANOPROST; REGISTRATION NO/DATE IN FRANCE: NL 22549 DU 19970724; REGISTRATION NO/DATE AT EEC: 12716 DU 19960718
0364417	9690031-1	Sweden	⤷ Try a Trial	PRODUCT NAME: LATANOPROST
1429780	SPC/GB12/058	United Kingdom	⤷ Try a Trial	PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003
0364417	97C0111	Belgium	⤷ Try a Trial	PRODUCT NAME: LATANOPROSTUM; NAT. REGISTRATION NO/DATE: 277 IS 271 F 13 19970617; FIRST REGISTRATION: SE 12716 1996071
1586316	122011100019	Germany	⤷ Try a Trial	PRODUCT NAME: BROMFENAC (2-AMINO-3-(4-BROMOBENZOYL)PHENYLESSIGSAEURE); REGISTRATION NO/DATE: EU/1/11/692/001 20110518
3461484	21C1024	France	⤷ Try a Trial	PRODUCT NAME: ASSOCIATION DE NETARSUDIL OU L'UN DE SES SELS ET DE LATANOPROST; REGISTRATION NO/DATE: EU/1/20/1502 20210108
0227494	95C0013	Belgium	⤷ Try a Trial	PRODUCT NAME: TIMOLOLI MALEAS EQ. TIMOLOLUM; NATIONAL REGISTRATION/DATE: 922 IS 166 F 13 19950627; FIRST REGISTRATION: SE 11901 19930910
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.